Halozyme launches offering of $500M convertible senior notes [Seeking Alpha]
Halozyme Therapeutics, Inc. (HALO)
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
halozyme.com/investors/default.aspx
Company Research
Source: Seeking Alpha
Halozyme launches offering of $500M convertible senior notesAug. 15, 2022 7:24 AM ETHalozyme Therapeutics, Inc. (HALO)By:Preeti SinghSA News EditorHalozyme Therapeutics (NASDAQ:announcedThe notes are to be offered and sold to "qualified institutional buyers." They will accrue interest payable semi-annually in arrears and will mature on August 15, 2028, unlessearlier redeemed, repurchased or converted.Initial purchasers will be granted a 13-day option to purchase up to an additional $75M of the convertible notes.In connection with the offering, the company intends to enter into privately negotiated capped call transactions with option counterparties that may include one or more of the initial purchasers and/or their affiliates and/or other institutions. These transactions are generally expected to reduce potential dilution to the company's common stock upon conversion of the convertible notes and/or offset any cash payments the company is required to make in excess of the principal amo
Show less
Read more
Impact Snapshot
Event Time:
HALO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HALO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HALO alerts
High impacting Halozyme Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HALO
News
- Mahesh Krishnan Elected to Halozyme's Board of Directors [Yahoo! Finance]Yahoo! Finance
- Mahesh Krishnan Elected to Halozyme's Board of DirectorsPR Newswire
- Why This 1 Value Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]Yahoo! Finance
- Halozyme to Report First Quarter 2024 Financial and Operating Results [Yahoo! Finance]Yahoo! Finance
- Halozyme to Report First Quarter 2024 Financial and Operating ResultsPR Newswire
HALO
Earnings
- 2/20/24 - Beat
HALO
Sec Filings
- 4/25/24 - Form 3
- 4/17/24 - Form 4
- 4/17/24 - Form 144
- HALO's page on the SEC website